large cell neuroendocrine carcinoma (Cancer)
Information
- Disease name
- large cell neuroendocrine carcinoma
- Disease ID
- DOID:0050872
- Description
- "A lung large cell carcinoma that derives_from neuroendocrine cells." [url:https\://www.ncbi.nlm.nih.gov/pubmed/15999058]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03728361 | Active, not recruiting | Phase 2 | Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer | December 31, 2018 | December 31, 2024 |
| NCT03866382 | Recruiting | Phase 2 | Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors | May 13, 2019 | February 28, 2025 |
- Disase is a (Disease Ontology)
- DOID:4556
- Cross Reference ID (Disease Ontology)
- ICDO:8013/3